You're using an older browser that may not provide the best experience on our site - for optimal performance and security, please update your browser.
Past performance is not indicative of future results. The value of fund units/shares can rise as well as fall and you may not get back the amount you invested. Funds with a risk level of 5-7 according to the fund’s key information document (KID) can both decrease and increase significantly in value. Fund information, including the KID, prospectus, and sustainability-related disclosures can be found at www.sebgroup.lu/funds.
We, at SEB Funds AB, will merge the Luxembourg-domiciled SEB Concept Biotechnology with the Swedish-domiciled SEB Läkemedelsfond. The merger will be effective 8 September 2025.
The merger aims to simplify and streamline the fund offering while enhancing the efficiency of fund management.
This is a merger by absorption, whereby the merging fund's holdings, including its assets and liabilities, will be transferred to the receiving fund. The merging fund will be dissolved without liquidation.
If you are an investor of the merging fund at the time of the merger, you will instead receive units in the receiving fund.
You are not required to take any action concerning this merger. The value of your investment will not be affected, but it is important for you to be aware of the merger.
The primary difference between the funds is that the merging fund has a more focused investment universe, specifically targeting the Biotechnology sector, which is a subsector of the broader Healthcare sector targeted by the receiving fund.
| SEB Concept Biotechnology (merging fund) | SEB Läkemedelsfond (receiving fund) |
| C (EUR) LU0385485148 | C (EUR) SE0024788731 |
| D (EUR) LU0118405827 | D (EUR) SE0024788749 |
| D (USD), LU2553409058 | E (USD) SE0024788756 |
| UC (EUR) LU2249630927 | F (EUR) SE0024788764 |
| UD (USD) LU2553409132 | G (USD) SE0024788772 |
If you wish to redeem your holdings in the merging fund before the merger takes place, the following timeframe applies:
29 August 2025: After cut-off time, the merging fund closes for transactions.
8 September 2025: The merger will be implemented.